What is the incidence of new asymptomatic brain lesions in patients undergoing laserballoon-based PVI for atrial fibrillation?
This study aims to determine the incidence of silent brain lesions following laserballoon-based PVI, addressing a gap in safety data for this specific atrial fibrillation ablation technology.
AimsLaserballoon-based pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF) has proven safe and effective. Silent brain lesions after AF ablation detected on magnetic resonance imaging (MRI) have been described for several technologies, but its incidence following laserballoon PVI is unknown. The current study sought to assess the incidence of new asymptomatic brain lesions in patients undergoing laserballoon-based PVI.
Wißner et al. (Fri,) studied this question.